These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16950295)

  • 1. Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization.
    Gabler M; Scheiblhofer S; Kern K; Leitner WW; Stoecklinger A; Hauser-Kronberger C; Alinger B; Lechner B; Prinz M; Vrtala S; Valenta R; Thalhamer J; Weiss R
    J Allergy Clin Immunol; 2006 Sep; 118(3):734-41. PubMed ID: 16950295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy.
    Scheiblhofer S; Stoecklinger A; Gruber C; Hauser-Kronberger C; Alinger B; Hammerl P; Thalhamer J; Weiss R
    Mol Immunol; 2007 Mar; 44(8):1879-87. PubMed ID: 17070909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens.
    Roesler E; Weiss R; Weinberger EE; Fruehwirth A; Stoecklinger A; Mostböck S; Ferreira F; Thalhamer J; Scheiblhofer S
    J Allergy Clin Immunol; 2009 Nov; 124(5):1070-7.e1-11. PubMed ID: 19665781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mimotope gene encoding the major IgE epitope of allergen Phl p 5 for epitope-specific immunization.
    Wallmann J; Proell M; Stepanoska T; Hantusch B; Pali-Schöll I; Thalhamer T; Thalhamer J; Jensen-Jarolim E; Hartl A
    Immunol Lett; 2009 Jan; 122(1):68-75. PubMed ID: 19111573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.
    Scheiblhofer S; Gabler M; Leitner WW; Bauer R; Zoegg T; Ferreira F; Thalhamer J; Weiss R
    Allergy; 2006 Jul; 61(7):828-35. PubMed ID: 16792580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
    Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
    Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1.
    Jacquet A; Magi M; Haumont M; Jurado M; Garcia L; Bollen A
    Clin Exp Allergy; 2003 Feb; 33(2):218-25. PubMed ID: 12580915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen.
    Hartl A; Kiesslich J; Weiss R; Bernhaupt A; Mostböck S; Scheiblhofer S; Ebner C; Ferreira F; Thalhamer J
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):107-13. PubMed ID: 9893193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1.
    Hochreiter R; Ferreira F; Thalhamer J; Hammerl P
    J Allergy Clin Immunol; 2003 Sep; 112(3):579-84. PubMed ID: 13679818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
    Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
    Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.
    Weinberger EE; Isakovic A; Scheiblhofer S; Ramsauer C; Reiter K; Hauser-Kronberger C; Thalhamer J; Weiss R
    Vaccine; 2013 Dec; 31(51):6113-21. PubMed ID: 23954383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprophylaxis with DNA vaccination inhibits Th2-mediated responses and airway inflammation in mice sensitised with the major timothy grass pollen allergen Phl p 5b.
    Darcan Y; Petersen A; Becker WM; Galle J; Ernst M; Ahmed J; Seitzer U
    Vaccine; 2005 Jul; 23(33):4203-11. PubMed ID: 15904999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replicase-based DNA vaccines for allergy treatment.
    Scheiblhofer S; Weiss R; Gabler M; Leitner WW; Thalhamer J
    Methods Mol Med; 2006; 127():221-35. PubMed ID: 16988457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
    Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
    J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen.
    Bauer R; Himly M; Dedic A; Ferreira F; Thalhamer J; Hartl A
    Allergy; 2003 Oct; 58(10):1003-10. PubMed ID: 14510717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A.
    Kirman JR; Turon T; Su H; Li A; Kraus C; Polo JM; Belisle J; Morris S; Seder RA
    Infect Immun; 2003 Jan; 71(1):575-9. PubMed ID: 12496215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
    Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
    Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity.
    Vrtala S; Focke M; Kopec J; Verdino P; Hartl A; Sperr WR; Fedorov AA; Ball T; Almo S; Valent P; Thalhamer J; Keller W; Valenta R
    J Immunol; 2007 Aug; 179(3):1730-9. PubMed ID: 17641039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.
    Marazuela EG; Rodríguez R; Fernández-García H; García MS; Villalba M; Batanero E
    Mol Immunol; 2008 Jan; 45(2):438-45. PubMed ID: 17662454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.